Nanotechnology
CytImmune To Present At ASCO
Published in Biotech Law Weekly, April 27th, 2007
CytImmune, a clinical stage nanomedicine company focused on the development and commercialization of multifunctional, tumor-targeted therapies has been selected to present a poster abstract at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago Illinois, June 1-5. The poster session will take place from 8:00 am to 12 noon on June 3. Dr. Lawrence Tamarkin, CEO of CytImmune will present the poster abstract entitled "Preliminary Results of a Phase I clinical trial of CYT-6091: A pegylated colloidal gold TNF nanomedicine.
"Acceptance to ASCO provides CytImmune the opportunity to present its research to the leading body of international oncology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-04-27)
More Articles from Biotech Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Files Registration Statement for a Common Stock Offering - Altus Pharmaceuticals Inc.
Altus Pharmaceuticals Announces Public Offering of Common Stock - American Physicians Assurance Corporation
Constitutionality of Tort Reforms Not yet Tested; Stakes Are High for Illinois Physicians - Anesthesia
Dallas Jury Awards Doctor $6.3 Million in Lawsuit Against Physicians' Group; Wrongful firing led to slander, breach of contract complaints - Asbestos Disease Awareness Organization (ADAO)
ADAO Demands Justice for Congressional Tunnel Workers - Cancer
AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
